Journal articleN Engl J Med2019
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
- Journal
- N Engl J Med
- Published
- 2 June 2019
- Citations
- 1,877
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 8
- BackgroundUsing Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620↗
- BackgroundCisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency NCT06095141↗
- BackgroundPancreatic Cancer Detection Consortium NCT06388967↗
- BackgroundPatient-derived Organoids Drug Screen in Pancreatic Cancer NCT05351983↗
- BackgroundExploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With … NCT04787991↗
- BackgroundGermline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico NCT05305001↗
- BackgroundProspectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis NCT02869802↗
- BackgroundOlaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy NCT02184195↗